Showing results (471-480 of 1,030) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|March 25, 2024
Efficacy of oral corticosteroids for acute preschool wheeze: a systematic review and individual participant data meta-analysis of randomised clinical trialsBohee Lee, Steve Turner, Meredith Borland, et al.
The Lancet. Respiratory Medicine|September 21, 2024
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trialZe-Rui Zhao, Shi-Liang Liu, Ting Zhou, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Early-life respiratory syncytial virus disease and long-term respiratory healthHeather J Zar, Ferdinand Cacho, Tahira Kootbodien, et al.
The Lancet. Respiratory Medicine|November 16, 2023
Unravelling the respiratory health path across the lifespan for survivors of preterm birthShannon J Simpson, Cassidy Du Berry, Denby J Evans, et al.
The Lancet. Respiratory Medicine|October 28, 2023
Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
The Lancet. Respiratory Medicine|November 13, 2023
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension studyLeonard B Bacharier, Jorge F Maspero, Constance H Katelaris, et al.
The Lancet. Respiratory Medicine|August 17, 2023
Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal managementMarion Delcroix, Marc de Perrot, Xavier Jaïs, et al.
The Lancet. Respiratory Medicine|August 26, 2023
Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trialsPratik Sinha, V Eric Kerchberger, Andrew Willmore, et al.
The Lancet. Respiratory Medicine|September 16, 2023
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trialGustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
The Lancet. Respiratory Medicine|September 12, 2023
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveNicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, et al.
Pageof 103